If Kroger is anything like many grocery chains, it’s doing everything it can to keep its customers from buying new vaccines.
In fact, the chain is planning to roll out its next vaccine in 2019 at the earliest.
Kroger has said it will start distributing the floridaparavirus vaccine to grocery stores and pharmacies on December 1, and the vaccine will be offered at Kroger Supercenters and Kroger stores on December 9, 2020.
It’s a move that will help Kroger save money by eliminating the cost of administering the flu vaccine and it’s also a sign that the company has made good on its promise to stop vaccinating people with the flus in the United States.
“We are going to make it easy for customers to buy and take our next flu vaccine,” Kroger said in a statement, noting that the vaccine is already available in most Kroger grocery stores.
“Our goal is to have a robust flu vaccination program by the end of the year.”
Kroger announced a partnership with Pfizer and other companies in September to expand the distribution of the flu vaccines in its stores.
Pfizer said in September that it would start vaccinating store employees in late October.
It is also working with the Centers for Disease Control and Prevention to distribute flu shots at more than 500 grocery stores in the U.S. and Canada by the start of December.
Krogers spokesperson David Tischler told NBC News that the new vaccine will cost $400 to $500 per month and will be delivered to the stores through mail-in packages.
Kroger’s flus announcement came on the same day that the Department of Health and Human Services announced that it was launching an investigation into Kroger.
The federal agency said it is looking into whether the grocery chain has violated the Food, Drug, and Cosmetic Act, which regulates the marketing and distribution of vaccines.
In a statement to NBC News, a spokesperson for the Department said: “It is our goal to ensure that Kroger, like every other vaccine company, continues to offer effective vaccines to our customers.”
Kobach has said that it will continue to sell flus vaccines until the federal investigation is over.
The Department of Justice announced earlier this year that it is reviewing the case.